FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2015145608> ?p ?o ?g. }

• W2015145608 endingPage "1096" @default.
• W2015145608 startingPage "1088" @default.
• W2015145608 abstract "<h3>Objective</h3> Cortactin acts as a prominent substrate of histone deacetylases (HDACs) and plays important roles in tumour progression in several human cancers. However, the clinical significance of its expression in human prostate cancer (PCa) has not been determined. We aimed to identify the potential role of cortactin expression in tumour progression and prognosis in PCa and the association with HDACs. <h3>Methods</h3> 256 foci with distinctive lesions in 110 prostate specimens were collected to identify the status of among cortactin, SIRT2, histone deacetylase 6 (HDAC6) by immunohistochemistry and its relationship with clinicopathological and follow-up data were analysed. <h3>Results</h3> The results showed that cortactin expression was significantly higher (79.1%), and SIRT2 expression was lower (37.3%) in PCa foci, when it was compared with high-grade prostatic intraepithelial neoplasia foci and benign foci, respectively. HDAC6 expression was low and had no statistical significance in PCa. High intensity of cortactin staining was significantly and independently associated with a high prostate-specific antigen (PSA) level, high Gleason score, clinical stage progression and shortened survival time in patients with PCa. High intensity of SIRT2 staining was significantly and independently associated with a high PSA level, old age, high Gleason score and clinical stage progression. Multivariable Cox regression analysis showed cortactin expression was a significant prognostic factor for survival of patients with PCa (β, 0.736; 95% CI 1.371 to 3.181; p=0.001). <h3>Conclusions</h3> The results suggested that cortactin seems to be a satisfactory marker to predict tumour progression and survival in cases of PCa. And it may be SIRT2 rather than HADAC6 is responsible for tumour occurrence and the progression of PCa." @default.
• W2015145608 created "2016-06-24" @default.
• W2015145608 creator A5015102287 @default.
• W2015145608 creator A5016082098 @default.
• W2015145608 creator A5017541508 @default.
• W2015145608 creator A5019018136 @default.
• W2015145608 creator A5039590366 @default.
• W2015145608 creator A5044216914 @default.
• W2015145608 creator A5053823318 @default.
• W2015145608 creator A5058755543 @default.
• W2015145608 creator A5059949850 @default.
• W2015145608 creator A5070078107 @default.
• W2015145608 creator A5088543620 @default.
• W2015145608 creator A5089791620 @default.
• W2015145608 date "2012-09-03" @default.
• W2015145608 modified "2023-10-03" @default.
• W2015145608 title "Cortactin is associated with tumour progression and poor prognosis in prostate cancer and SIRT2 other than HADC6 may work as facilitator in situ" @default.
• W2015145608 cites W182048401 @default.
• W2015145608 cites W1974133264 @default.
• W2015145608 cites W1976701714 @default.
• W2015145608 cites W1998499089 @default.
• W2015145608 cites W2000690392 @default.
• W2015145608 cites W2017410521 @default.
• W2015145608 cites W2023506783 @default.
• W2015145608 cites W2031079181 @default.
• W2015145608 cites W2032905675 @default.
• W2015145608 cites W2038055198 @default.
• W2015145608 cites W2066531385 @default.
• W2015145608 cites W2067750483 @default.
• W2015145608 cites W2080483074 @default.
• W2015145608 cites W2085492709 @default.
• W2015145608 cites W2086125062 @default.
• W2015145608 cites W2097631732 @default.
• W2015145608 cites W2100275705 @default.
• W2015145608 cites W2107150099 @default.
• W2015145608 cites W2107218095 @default.
• W2015145608 cites W2111102277 @default.
• W2015145608 cites W2112059293 @default.
• W2015145608 cites W2112795897 @default.
• W2015145608 cites W2115281215 @default.
• W2015145608 cites W2117298794 @default.
• W2015145608 cites W2137659645 @default.
• W2015145608 cites W2138840986 @default.
• W2015145608 cites W2148516870 @default.
• W2015145608 cites W2160451428 @default.
• W2015145608 cites W2165463461 @default.
• W2015145608 cites W2168702014 @default.
• W2015145608 cites W2169964349 @default.
• W2015145608 cites W2171012735 @default.
• W2015145608 doi "https://doi.org/10.1136/jclinpath-2012-200940" @default.
• W2015145608 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/22944623" @default.
• W2015145608 hasPublicationYear "2012" @default.
• W2015145608 type Work @default.
• W2015145608 sameAs 2015145608 @default.
• W2015145608 citedByCount "29" @default.
• W2015145608 countsByYear W20151456082013 @default.
• W2015145608 countsByYear W20151456082014 @default.
• W2015145608 countsByYear W20151456082015 @default.
• W2015145608 countsByYear W20151456082016 @default.
• W2015145608 countsByYear W20151456082017 @default.
• W2015145608 countsByYear W20151456082018 @default.
• W2015145608 countsByYear W20151456082019 @default.
• W2015145608 countsByYear W20151456082020 @default.
• W2015145608 countsByYear W20151456082021 @default.
• W2015145608 crossrefType "journal-article" @default.
• W2015145608 hasAuthorship W2015145608A5015102287 @default.
• W2015145608 hasAuthorship W2015145608A5016082098 @default.
• W2015145608 hasAuthorship W2015145608A5017541508 @default.
• W2015145608 hasAuthorship W2015145608A5019018136 @default.
• W2015145608 hasAuthorship W2015145608A5039590366 @default.
• W2015145608 hasAuthorship W2015145608A5044216914 @default.
• W2015145608 hasAuthorship W2015145608A5053823318 @default.
• W2015145608 hasAuthorship W2015145608A5058755543 @default.
• W2015145608 hasAuthorship W2015145608A5059949850 @default.
• W2015145608 hasAuthorship W2015145608A5070078107 @default.
• W2015145608 hasAuthorship W2015145608A5088543620 @default.
• W2015145608 hasAuthorship W2015145608A5089791620 @default.
• W2015145608 hasConcept C121608353 @default.
• W2015145608 hasConcept C126322002 @default.
• W2015145608 hasConcept C142669718 @default.
• W2015145608 hasConcept C142724271 @default.
• W2015145608 hasConcept C143998085 @default.
• W2015145608 hasConcept C1491633281 @default.
• W2015145608 hasConcept C204232928 @default.
• W2015145608 hasConcept C2776000893 @default.
• W2015145608 hasConcept C2776235491 @default.
• W2015145608 hasConcept C2779256057 @default.
• W2015145608 hasConcept C2780192828 @default.
• W2015145608 hasConcept C502942594 @default.
• W2015145608 hasConcept C54355233 @default.
• W2015145608 hasConcept C71924100 @default.
• W2015145608 hasConcept C86803240 @default.
• W2015145608 hasConceptScore W2015145608C121608353 @default.
• W2015145608 hasConceptScore W2015145608C126322002 @default.
• W2015145608 hasConceptScore W2015145608C142669718 @default.
• W2015145608 hasConceptScore W2015145608C142724271 @default.
• W2015145608 hasConceptScore W2015145608C143998085 @default.
• W2015145608 hasConceptScore W2015145608C1491633281 @default.

• next